Gene signatures in the management of hepatocellular carcinoma

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 473-485

  Hoshida, Yujin ^a   Moeini, Agrin ^b,c   Alsinet, Clara ^b,c   Kojima, Kensuke ^a   Villanueva, Augusto ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CDKL2 PROTEIN; CTNNB1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; GENOMIC RNA; GLUL PROTEIN; GLUTATHIONE TRANSFERASE P1; HIST1H3G PROTEIN; LECT2 PROTEIN; LGR5 PROTEIN; PEPTIDES AND PROTEINS; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SECRETED FRIZZLED RELATED PROTEIN 1; SORAFENIB; STEAP4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; ZNF154 PROTEIN;

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MOLECULAR GENETICS; ONCOGENE; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 84864455290     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.003     Document Type: Conference Paper

References (123)

1. L.A. Garraway, H.R. Widlund, M.A. Rubin Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 436 2005 117 122
2. D.E. Gerber, J.D. Minna ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time Cancer Cell 18 2010 548 551
3. A. Villanueva, J.M. Llovet Targeted therapies for hepatocellular carcinoma Gastroenterology 140 2011 1410 1426
4. Y. Hoshida, S. Toffanin, A. Lachenmayer, A. Villanueva, B. Minguez, J.M. Llovet Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Semin Liver Dis 30 1 2010 35 51
5. A. Villanueva, Y. Hoshida, S. Toffanin New strategies in hepatocellular carcinoma: genomic prognostic markers Clin Cancer Res 16 2010 4688 4694
6. J.P. Ioannidis, O.A. Panagiotou Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses JAMA 305 2011 2200 2210
7. S. Michiels, S. Koscielny, C. Hill Prediction of cancer outcome with microarrays: a multiple random validation strategy Lancet 365 2005 488 492
8. T.J. Lynch, D.W. Bell, R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
9. D. Ge, J. Fellay, A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
10. E.E. Schadt Molecular networks as sensors and drivers of common human diseases Nature 461 2009 218 223
11. L.J. van't Veer, R. Bernards Enabling personalized cancer medicine through analysis of gene-expression patterns Nature 452 2008 564 570
12. J.E. Dancey, P.L. Bedard, N. Onetto, T.J. Hudson The genetic basis for cancer treatment decisions Cell 148 2012 409 420
13. Y. Hoshida Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment PLoS One 5 2010 e15543
14. A. Subramanian, P. Tamayo, V.K. Mootha Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550
15. F. Cardoso, L. Van't Veer, E. Rutgers Clinical application of the 70-gene profile: the MINDACT trial J Clin Oncol 26 2008 729 735
16. J.A. Sparano, S. Paik Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol 26 2008 721 728
17. I.B. Tan, P. Tan Genetics: an 18-gene signature (ColoPrint) for colon cancer prognosis Nat Rev Clin Oncol 8 2011 131 133
18. A. Dupuy, R.M. Simon Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting J Natl Cancer Inst 99 2007 147 157
19. J. Lamb, E.D. Crawford, D. Peck The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
20. A. Villanueva, Y. Hoshida, C. Battiston Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma Gastroenterology 140 2011 1501 1512 e2
21. C. Fan, D.S. Oh, L. Wessels Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 2006 560 569
22. J.P. Ioannidis, M.J. Khoury Improving validation practices in "omics" research Science 334 2011 1230 1232
23. N.L. Henry, D.F. Hayes Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer Oncologist 11 2006 541 552
24. L.M. McShane, D.G. Altman, W. Sauerbrei Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 97 2005 1180 1184
25. R.M. Simon, S. Paik, D.F. Hayes Use of archived specimens in evaluation of prognostic and predictive biomarkers J Natl Cancer Inst 101 2009 1446 1452
26. G.K. Geiss, R.E. Bumgarner, B. Birditt Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
27. E. Schadt Genome-sequencing anniversary First steps on a long road Science 331 2011 691
28. Z. Zhang, D.W. Chan The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers Cancer Epidemiol Biomarkers Prev 19 2010 2995 2999
29. Y. Hoshida, S.M. Nijman, M. Kobayashi Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
30. D.Y. Chiang, A. Villanueva, Y. Hoshida Focal gains of VEGFA and molecular classification of hepatocellular carcinoma Cancer Res 68 2008 6779 6788
31. J. Zucman-Rossi, S. Benhamouche, C. Godard Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas Oncogene 26 2007 774 780
32. C. Coulouarn, V.M. Factor, S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067
33. B.D. White, A.J. Chien, D.W. Dawson Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers Gastroenterology 142 2012 219 232
34. V. Mazzaferro, J.M. Llovet, R. Miceli Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
35. S. Roayaie, I.N. Blume, S.N. Thung A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma Gastroenterology 137 2009 850 855
36. B. Minguez, Y. Hoshida, A. Villanueva Gene-expression signature of vascular invasion in hepatocellular carcinoma J Hepatol 55 2011 1325 1331
37. Y. Hoshida, A. Villanueva, M. Kobayashi Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
38. A. Budhu, M. Forgues, Q.H. Ye Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 2006 99 111
39. Y. Hoshida, A. Villanueva, A. Sangiovanni Gene-expression signature predicts outcome of liver cirrhosis Hepatology 50 2009 312A
40. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
41. M.F. Yuen, J.L. Hou, A. Chutaputti Hepatocellular carcinoma in the Asia pacific region J Gastroenterol Hepatol 24 2009 346 353
42. Y. Hoshida, B.C. Fuchs, K.K. Tanabe Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Curr Cancer Drug Targets 2012 [In press]
43. J. Bruix, M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
44. Y. Hoshida, A. Villanueva, J.M. Llovet Molecular profiling to predict hepatocellular carcinoma outcome Expert Rev Gastroenterol Hepatol 3 2009 101 103
45. H. Imamura, Y. Matsuyama, E. Tanaka Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 2003 200 207
46. S. Roessler, H.L. Jia, A. Budhu A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res 70 2010 10202 10212
47. R. Simon The use of genomics in clinical trial design Clin Cancer Res 14 2008 5984 5993
48. E.H. Rubin, D.G. Gilliland Drug development and clinical trials-the path to an approved cancer drug Nat Rev Clin Oncol 9 2012 215 222
49. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
50. M. Diehn, C. Nardini, D.S. Wang Identification of noninvasive imaging surrogates for brain tumor gene-expression modules Proc Natl Acad Sci U S A 105 2008 5213 5218
51. M.D. Kuo, J. Gollub, C.B. Sirlin Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma J Vasc Interv Radiol 18 2007 821 831
52. E. Segal, C.B. Sirlin, C. Ooi Decoding global gene expression programs in liver cancer by noninvasive imaging Nat Biotechnol 25 2007 675 680
53. X. Chen, S.T. Cheung, S. So Gene expression patterns in human liver cancers Mol Biol Cell 13 2002 1929 1939
54. H. Chang, B. Yi, L. Li Methylation of tumor associated genes in tissue and plasma samples from liver disease patients Exp Mol Pathol 85 2008 96 100
55. D. Hua, Y. Hu, Y.Y. Wu Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma Exp Mol Pathol 91 2011 455 460
56. Z.H. Huang, Y. Hu, D. Hua Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma Exp Mol Pathol 91 2011 702 707
57. P. Iyer, A.R. Zekri, C.W. Hung Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients Exp Mol Pathol 88 2010 107 111
58. J.B. Liu, Y.X. Zhang, S.H. Zhou CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis World J Gastroenterol 17 2011 4718 4724
59. J. Wang, Y. Qin, B. Li, Z. Sun, B. Yang Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients Clin Biochem 39 2006 344 348
60. W. Yeo, N. Wong, W.L. Wong, P.B. Lai, S. Zhong, P.J. Johnson High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma Liver Int 25 2005 266 272
61. Y.J. Zhang, H.C. Wu, J. Shen Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA Clin Cancer Res 13 2007 2378 2384
62. J. Shen, S. Wang, Y.J. Zhang Genome-wide DNA methylation profiles in hepatocellular carcinoma Hepatology 55 2012 1799 1808
63. L.M. Li, Z.B. Hu, Z.X. Zhou Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma Cancer Res 70 2010 9798 9807
64. K.Z. Qu, K. Zhang, H. Li, N.H. Afdhal, M. Albitar Circulating microRNAs as biomarkers for hepatocellular carcinoma J Clin Gastroenterol 45 2011 355 360
65. J. Xu, C. Wu, X. Che Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis Mol Carcinog 50 2011 136 142
66. S. Cermelli, A. Ruggieri, J.A. Marrero, G.N. Ioannou, L. Beretta Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease PLoS One 6 2011 e23937
67. P. Qi, S.Q. Cheng, H. Wang, N. Li, Y.F. Chen, C.F. Gao Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection PLoS One 6 2011 e28486
68. K. Wang, S. Zhang, B. Marzolf Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc Natl Acad Sci U S A 106 2009 4402 4407
69. J. Zhou, L. Yu, X. Gao Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma J Clin Oncol 29 2011 4781 4788
70. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, X. Du Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int J Cancer 127 2011 118 126
71. E.K. Ng, W.W. Chong, H. Jin Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
72. K.E. Resnick, H. Alder, J.P. Hagan, D.L. Richardson, C.M. Croce, D.E. Cohn The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform Gynecol Oncol 112 2009 55 59
73. K.M. Foss, C. Sima, D. Ugolini, M. Neri, K.E. Allen, G.J. Weiss miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer J Thorac Oncol 6 2011 482 488
74. P.T. Hennessey, T. Sanford, A. Choudhary Serum microRNA biomarkers for detection of non-small cell lung cancer PLoS One 7 2012 e32307
75. J. Shen, N.W. Todd, H. Zhang Plasma microRNAs as potential biomarkers for non-small-cell lung cancer Lab Invest 91 2011 579 587
76. T.R. Ashworth A case of cancer in which cells similar to those in the tumours were seen in the blood after death Aust Med J 14 1869 146 147
77. M. Cristofanilli, G.T. Budd, M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
78. M.C. Liu, P.G. Shields, R.D. Warren Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer J Clin Oncol 27 2009 5153 5159
79. M.S. Wicha, D.F. Hayes Circulating tumor cells: not all detected cells are bad and not all bad cells are detected J Clin Oncol 29 2011 1508 1511
80. S. Nagrath, L.V. Sequist, S. Maheswaran Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 2007 1235 1239
81. S.L. Stott, C.H. Hsu, D.I. Tsukrov Isolation of circulating tumor cells using a microvortex-generating herringbone-chip Proc Natl Acad Sci U S A 107 2010 18392 18397
82. W. Xu, L. Cao, L. Chen Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy Clin Cancer Res 17 2011 3783 3793
83. Y. Hou, L. Song, P. Zhu Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm Cell 148 2012 873 885
84. T. Yamashita, M. Forgues, W. Wang EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
85. T. Yamashita, J. Ji, A. Budhu EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
86. J.S. Lee, J. Heo, L. Libbrecht A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
87. H. Cornella, A. Villanueva Genomic tracing of the elusive liver cancer ancestor J Hepatol 53 2010 578 579
88. N. Waguri, T. Suda, M. Nomoto Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation Clin Cancer Res 9 2003 3004 3011
89. G. Vona, L. Estepa, C. Beroud Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer Hepatology 39 2004 792 797
90. + cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
91. J.S. Lee, I.S. Chu, J. Heo Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 403 2004 667 676
92. P. Kaposi-Novak, J.S. Lee, L. Gomez-Quiroz, C. Coulouarn, V.M. Factor, S.S. Thorgeirsson Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype J Clin Invest 1166 2006 1582 1595
93. J.B. Andersen, R. Loi, A. Perra Progenitor-derived hepatocellular carcinoma model in the rat Hepatology 514 2010 1401 1409
94. J.U. Marquardt, C. Raggi, J.B. Andersen Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways Hepatology 543 2011 1031 1042
95. S. Boyault, D.S. Rickman, A. de Reynies Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 451 2007 42 52
96. Q.H. Ye, L.X. Qin, M. Forgues Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 94 2003 416 423
97. H.G. Woo, J.H. Lee, J.H. Yoon Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 708 2010 3034 3041
98. S.M. Kim, S.H. Leem, I.S. Chu Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma Hepatology 555 2012 1443 1452
99. I. Ivanovska, C. Zhang, A.M. Liu Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma PLoS One 69 2011 e24582
100. B.Y. Kim, K.S. Suh, J.G. Lee Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue Ann Surg Oncol 2011 10.1245/s10434-011-1709-0
101. Q. Gao, X.Y. Wang, S.J. Qiu Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma Cancer Sci 1028 2011 1522 1531
102. S.M. Wang, L.L. Ooi, K.M. Hui Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma Clin Cancer Res 1321 2007 6275 6283
103. N. Iizuka, M. Oka, H. Yamada-Okabe Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 3619361 2003 923 929
104. Y. Kurokawa, R. Matoba, I. Takemasa Molecular-based prediction of early recurrence in hepatocellular carcinoma J Hepatol 412 2004 284 291
105. H.G. Woo, E.S. Park, J.H. Cheon Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma Clin Cancer Res 147 2008 2056 2064
106. S. Yoshioka, I. Takemasa, H. Nagano Molecular prediction of early recurrence after resection of hepatocellular carcinoma Eur J Cancer 455 2009 881 889
107. H.L. Jia, Q.H. Ye, L.X. Qin Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma Clin Cancer Res 134 2007 1133 1139
108. J.M. Llovet, Y. Chen, E. Wurmbach A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis Gastroenterology 1316 2006 1758 1767
109. J. Jiang, Y. Gusev, I. Aderca Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival Clin Cancer Res 142 2008 419 427
110. A. Budhu, H.L. Jia, M. Forgues Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 473 2008 897 907
111. F. Sato, E. Hatano, K. Kitamura MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan criteria PLoS One 61 2011 e16435
112. S.R. Viswanathan, J.T. Powers, W. Einhorn Lin28 promotes transformation and is associated with advanced human malignancies Nat Genet 417 2009 843 848
113. H. Katoh, H. Ojima, A. Kokubu Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets Gastroenterology 1335 2007 1475 1486
114. P. Laurent-Puig, P. Legoix, O. Bluteau Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 1207 2001 1763 1773
115. D.F. Calvisi, S. Ladu, A. Gorden Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma J Clin Invest 1179 2007 2713 2722
116. B. Li, W. Liu, L. Wang CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma Ann Surg Oncol 177 2010 1917 1926
117. W. Gao, Y. Kondo, L. Shen Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas Carcinogenesis 2910 2008 1901 1910
118. C.H. Lin, S.Y. Hsieh, I.S. Sheen Genome-wide hypomethylation in hepatocellular carcinogenesis Cancer Res 6110 2001 4238 4243
119. H. Hernandez-Vargas, M.P. Lambert, F. Le Calvez-Kelm Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors PLoS One 53 2010 e9749
120. R. Tao, J. Li, J. Xin Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma PLoS One 65 2011 e19862
121. L. Shen, N. Ahuja, Y. Shen DNA methylation and environmental exposures in human hepatocellular carcinoma J Natl Cancer Inst 9410 2002 755 761
122. M. Okamoto, T. Utsunomiya, S. Wakiyama Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients Ann Surg Oncol 137 2006 947 954
123. M. Tsuchiya, J.S. Parker, H. Kono, M. Matsuda, H. Fujii, I. Rusyn Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma Mol Cancer 9 2010 74